These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2036032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
    Merot Y, Gravallese E, Guillén FJ, Murphy GF.
    Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M, Charue D, Heslan M, Wechsler J, Roujeau JC, Revuz J.
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.
    Correia O, Delgado L, Ramos JP, Resende C, Torrinha JA.
    Arch Dermatol; 1993 Apr; 129(4):466-8. PubMed ID: 8466217
    [Abstract] [Full Text] [Related]

  • 8. T-cell subsets in drug-induced toxic epidermal necrolysis.
    Hertl M, Merk HF, Bohlen H.
    Arch Dermatol; 1992 Feb; 128(2):272. PubMed ID: 1590854
    [No Abstract] [Full Text] [Related]

  • 9. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [Abstract] [Full Text] [Related]

  • 10. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.
    Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE.
    Arch Dermatol; 1994 May; 130(5):605-8. PubMed ID: 8179342
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
    Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellón T.
    J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
    Paquet P, Jacob E, Pirson J, Pierard GE.
    Int J Mol Med; 2005 Jul; 16(1):29-33. PubMed ID: 15942674
    [Abstract] [Full Text] [Related]

  • 18. Animal models of toxic epidermal necrolysis.
    Azukizawa H.
    J Dermatol; 2011 Mar; 38(3):255-60. PubMed ID: 21342227
    [Abstract] [Full Text] [Related]

  • 19. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
    Paquet P, Jacob E, Damas P, Pirson J, Piérard G.
    Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.